Details for Patent: 9,616,097
✉ Email this page to a colleague
Which drugs does patent 9,616,097 protect, and when does it expire?
Patent 9,616,097 protects TRULANCE and is included in one NDA.
This patent has twenty-three patent family members in eight countries.
Summary for Patent: 9,616,097
Title: | Formulations of guanylate cyclase C agonists and methods of use |
Abstract: | The invention provides low-dose formulations of guanylate cyclase-C ("GCC") agonist peptides and methods for their use. The formulations of the invention can be administered either alone or in combination with one or more additional therapeutic agents, preferably an inhibitor of cGMP-dependent phosphodiesterase or a laxative. |
Inventor(s): | Comiskey; Stephen (Doylestown, PA), Feng; Rong (Langhorne, PA), Foss; John (Doylestown, PA), Shailubhai; Kunwar (Audubon, PA) |
Assignee: | SYNERGY PHARMACEUTICALS, INC. (New York, NY) |
Application Number: | 13/421,769 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,616,097 |
Patent Claim Types: see list of patent claims | Composition; Formulation; Dosage form; | More… ↓ |
Drugs Protected by US Patent 9,616,097
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Salix | TRULANCE | plecanatide | TABLET;ORAL | 208745-001 | Jan 19, 2017 | RX | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | Y | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,616,097
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2011302006 | ⤷ Subscribe | |||
Australia | 2013232306 | ⤷ Subscribe | |||
Australia | 2016216716 | ⤷ Subscribe | |||
Australia | 2018286626 | ⤷ Subscribe | |||
Australia | 2020270511 | ⤷ Subscribe | |||
Canada | 2810243 | ⤷ Subscribe | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |